Reports for SANOFI-AVENTIS CANADA INC
Company Name
SANOFI-AVENTIS CANADA INC
Totals |
||
Shortage reports |
289 |
|
| Actual shortage: | 4 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 16 (6%) | |
| Resolved: | 269 (93%) | |
Discontinuation Reports |
58 |
|
| To be discontinued: | 7 (12%) | |
| Discontinued: | 51 (88%) | |
| Reversed: | 0 (0%) | |
Late reports |
21 (6%) |
|
Overdue reports |
6 (55%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYOCHRYSINE | 10MG | SOLUTION | Resolved | 2017-07-06 | 2017-08-04 | 14864 |
| MYOCHRYSINE | 10MG | SOLUTION | Resolved | 2018-02-09 | 2018-03-05 | 39185 |
| MYOCHRYSINE | 10MG | SOLUTION | Resolved | 2018-04-10 | 2019-06-10 | 45370 |
| MYOZYME | 50MG | POWDER FOR SOLUTION | Resolved | 2022-11-30 | 2022-12-07 | 176406 |
| NALCROM | 100MG | CAPSULE | Resolved | 2019-04-03 | 2019-06-26 | 80347 |
| NALCROM | 100MG | CAPSULE | Resolved | 2019-08-05 | 2019-08-24 | 90722 |
| NALCROM | 100MG | CAPSULE | Resolved | 2020-10-15 | 2020-11-25 | 126537 |
| NALCROM | 100MG | CAPSULE | Resolved | 2021-03-02 | 2021-05-22 | 134957 |
| NALCROM | 100MG | CAPSULE | Resolved | 2022-03-22 | 2022-03-28 | 157078 |
| NALCROM | 100MG | CAPSULE | Resolved | 2022-04-14 | 2022-05-04 | 158887 |
| NALCROM | 100MG | CAPSULE | Resolved | 2022-06-20 | 2022-09-24 | 163129 |
| NALCROM | 100MG | CAPSULE | Resolved | 2022-10-13 | 2023-07-01 | 171702 |
| NALCROM | 100MG | CAPSULE | Resolved | 2024-02-22 | 2024-10-07 | 220296 |
| NITROLINGUAL PUMPSPRAY | 0.4MG | METERED-DOSE PUMP | Resolved | 2018-01-10 | 2018-02-19 | 35649 |
| NITROLINGUAL PUMPSPRAY | 0.4MG | METERED-DOSE PUMP | Resolved | 2020-04-07 | 2020-04-15 | 111387 |
| NITROLINGUAL PUMPSPRAY | 0.4MG | METERED-DOSE PUMP | Resolved | 2022-12-07 | 2023-02-09 | 177219 |
| NITROLINGUAL PUMPSPRAY | 0.4MG | METERED-DOSE PUMP | Resolved | 2023-03-09 | 2024-05-03 | 186615 |
| NITROLINGUAL PUMPSPRAY | 0.4MG | METERED-DOSE PUMP | Resolved | 2023-03-09 | 2024-06-15 | 186618 |
| NOVAHISTEX DH | 20MG 5MG | SYRUP | Resolved | 2018-03-01 | 2018-05-08 | 41428 |
| PEDIAPRED | 5MG | SOLUTION | Resolved | 2017-11-01 | 2017-12-01 | 27673 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RENVELA | 2.4G | POWDER FOR SUSPENSION | Discontinued | 2024-10-04 | 2025-04-03 | 239436 |
| RENVELA | 0.8G | POWDER FOR SUSPENSION | Discontinued | 2024-10-04 | 2025-04-03 | 239433 |
| RENVELA | 800MG | TABLET | To be discontinued | 2025-03-31 | 2025-03-31 | 253680 |
| RIFADIN | 300MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134218 |
| RIFADIN | 150MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134215 |
| RIFATER | 300MG 120MG 50MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3688 |
| SECTRAL | 200MG | TABLET | Discontinued | 2018-07-09 | 2018-09-07 | 54767 |
| SECTRAL | 400MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3692 |
| SECTRAL | 100MG | TABLET | Discontinued | 2018-09-17 | 2018-10-03 | 61609 |
| TALWIN | 50MG | TABLET | Discontinued | 2020-11-09 | 2021-02-06 | 128146 |
| TALWIN | 50MG | TABLET | Discontinued | 2021-02-09 | 2021-02-09 | 133620 |
| TAXOTERE | 80MG | SOLUTION | To be discontinued | 2018-06-27 | 2018-10-17 | 53064 |
| TAXOTERE | 20MG | SOLUTION | Discontinued | 2018-02-23 | 2018-05-28 | 40870 |
| TUSSIONEX | 5MG 10MG | SUSPENSION | Discontinued | 2019-11-11 | 2020-03-24 | 98368 |
| TUSSIONEX | 5MG 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-08-17 | 2017-08-22 | 19700 |
| ZALTRAP | 200MG | SOLUTION | Discontinued | 2020-07-30 | 2020-07-30 | 121390 |
| ZALTRAP | 100MG | SOLUTION | Discontinued | 2020-07-30 | 2020-07-30 | 121387 |
| ZUACTA | 0.075% | CREAM | Discontinued | 2020-07-30 | 2020-07-30 | 121381 |